Clinical Trial Update: Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01) [Phase 2]

View source ↗

Summary

CASTLE-ZS-01 is a Phase 2 trial evaluating cryoablation in combination with lenvatinib and tislelizumab versus FOLFOX in patients with advanced intrahepatic cho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• LENVIMA (lenvatinib)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Fudan University | Conditions: Intrahepatic Cholangiocellular Carcinoma | Phase 2 | Status: RECRUITING